Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Eiger Biopharmaceuticals Inc buy melinda

Eiger Biopharmaceuticals Inc
Start price
€9.22
15.10.18 / 50%
Target price
€10.28
17.10.18
Performance (%)
13.75%
End price
€10.49
17.10.18
Summary
This prediction ended on 17.10.18 with a price of €10.49. The prediction had a final performance of 13.75%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Eiger Biopharmaceuticals Inc - - - -
iShares Core DAX® -0.922% -1.993% 13.399% 16.075%
iShares Nasdaq 100 0.371% -0.868% 41.541% 46.938%
iShares Nikkei 225® 2.224% -5.187% 20.497% 4.643%
iShares S&P 500 -0.026% -0.918% 30.410% 42.418%

Comments by melinda for this prediction

In the thread Eiger Biopharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 13.75%
Target price 10.283
Change
Ends at 17.10.18

SecteurRecherche biotechnologique et médicale Agenda 07/11 Publication de résultats



Métier
Logo Eiger Biopharmaceuticals I
Operates as a clinical-stage biopharmaceutical company

Eiger BioPharmaceuticals, Inc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for orphan diseases.

It focuses on product candidates for the treatment of orphan diseases such as Sarasar, Pegylated Interferon Lambda, Exendin 9-39, and Ubenimex.

The company was founded by David A. Cory on November 6, 2008 and is headquartered in Palo Alto, CA.

Nombre d'employés : 16 personnes.



melinda 
0
Report Share
15.10.18
Prediction Buy
Perf. (%) 13.75%
Target price 10.283
Change
Ends at 17.10.18

(Zielkurs erreicht)

melinda 
0
Report Share
17.10.18

Stopped prediction by melinda for Eiger Biopharmaceuticals Inc

buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€2.50
10.02.23
€4.00
10.02.24
-58.40%
31.05.23

melinda 
10.02.23 10%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.30
13.03.20
€9.00
04.11.21
28.02%
05.11.21

melinda 
13.03.20 50%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€13.30
02.04.19
€14.43
13.03.20
-60.16%
13.03.20

melinda 
18.08.19 50%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€12.36
12.10.17
€13.53
11.01.18
9.49%
11.01.18

melinda 
14.08.19 50%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€8.16
07.04.17
€9.92
15.09.17
23.20%
15.09.17

melinda 
14.08.19 50%